CN201823337U - Concentrating and crystallizing equipment for 5-hydroxyl tryptophan - Google Patents

Concentrating and crystallizing equipment for 5-hydroxyl tryptophan Download PDF

Info

Publication number
CN201823337U
CN201823337U CN2010205282942U CN201020528294U CN201823337U CN 201823337 U CN201823337 U CN 201823337U CN 2010205282942 U CN2010205282942 U CN 2010205282942U CN 201020528294 U CN201020528294 U CN 201020528294U CN 201823337 U CN201823337 U CN 201823337U
Authority
CN
China
Prior art keywords
tank
hydroxytryptophan
crystallizing
concentrating
equipment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010205282942U
Other languages
Chinese (zh)
Inventor
郑志忠
蒋荔馨
陈义
甘全明
林志华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xiamen Top Health Biological Engineering Co., Ltd.
Original Assignee
Yingjie Warner (xiamen) Biological Engineering Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yingjie Warner (xiamen) Biological Engineering Co Ltd filed Critical Yingjie Warner (xiamen) Biological Engineering Co Ltd
Priority to CN2010205282942U priority Critical patent/CN201823337U/en
Application granted granted Critical
Publication of CN201823337U publication Critical patent/CN201823337U/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/10Process efficiency

Landscapes

  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

The utility model discloses concentrating crystallizing equipment for 5-hydroxyl tryptophan, comprising a raw material tank, a material delivery pump, an ion exchange resin tank, an evaporator and a crystallizing tank which are connected in sequence by pipelines. The concentrating crystallizing equipment is further characterized in that the pipeline behind the ion exchange resin tank and in front of the evaporator is also provided with an intermediate material tank, a safety filter, a high pressure pump, a film concentrating device and a dialysis tank which are arranged in sequence. Compared with the traditional method of directly carrying out evaporation, in the concentrated crystallizing equipment, extracted solution of the 5-hydroxyl tryptophan is subjected to the film concentration firstly, and film concentration has the advantages that the energy is saved and the efficiency is high, therefore, the production cost is reduced.

Description

A kind of condensing crystallizing equipment of 5-hydroxytryptophan
Technical field
The utility model relates to a kind of condensing crystallizing equipment, particularly relates to a kind of condensing crystallizing equipment of 5-hydroxytryptophan.
Background technology
5-hydroxytryptophan (having another name called 5-hydroxy, 5-HTP) is a kind of natural amino acid, its chemistry 5-hydroxyl by name-3-indyl-α-An Jibingsuan, and molecular weight is 220.23.5-hydroxy mainly is to extract from Ghana's seed, and Ghana's seed is a tropical mesquite plant Ghana cereal Griffonia simplicifoliaDry seed, wild in the west African states such as Ghana, the Ivory Coast and Togo.5-hydroxy has the various biological effect, is important neurological drug and health care medicine raw material, and application is very extensive clinically, and important value and vast market prospect are arranged.
The extraction preparation method of 5-hydroxytryptophan adopts mostly at present: squeezing or benzinum de-oiling → water/solvent extraction → decolouring → filtration → concentrate → crystallization → recrystallization, and concentrating of the extract of 5-hydroxytryptophan mainly is to realize by evaporating concentration process, and wherein the equipment of evaporation and concentration use mainly is evaporimeter.Evaporation and concentration has the cycles of concentration advantages of higher, but evaporation and concentration liquid has shortcomings such as energy consumption is big, cost height.The 5-hydroxytryptophan content that the extracting liquid decoloration of 5-hydroxytryptophan filters in the solution of back is lower, if directly carry out evaporation and concentration, will increase evaporation cost and evaporation time greatly.
It is to occur in 20 beginnings of the century that film separates, a separation technology that emerges rapidly after the sixties in 20th century.Membrane separation technique is owing to have separations, concentrated, purifying and refining function concurrently, efficient, energy-saving and environmental protection are arranged again, molecular level filters and filter process is simple, be easy to feature such as control, therefore, fields such as food, medicine, biology, environmental protection, chemical industry, metallurgy, the energy, oil, water treatment, electronics have been widely used at present, produce huge economic benefit and social benefit, become one of most important means in the current separation science.
Summary of the invention
The utility model designs a kind of evaporation concentration equipment of 5-hydroxytryptophan of improvement at shortcomings such as traditional 5-hydroxytryptophan evaporation concentration equipment energy consumption height, reaches the purpose that reduces production costs.
For achieving the above object, the technical scheme that the utility model proposes is: a kind of condensing crystallizing equipment of 5-hydroxytryptophan, comprise the head tank that links to each other successively by pipeline, dehvery pump, the ion exchange resin jar, evaporimeter, crystallizing tank, after its feature also is the ion exchange resin jar, batch can in the middle of also being equipped with successively on the pipeline before the evaporimeter, security personnel's filter, high-pressure pump, valve, film condensing device and dialysate tank, and the film condensing device concentrated solution outlet links to each other with middle batch can by reflux line, link to each other with evaporimeter by concentrating pipeline, its feature also is on described reflux line and the concentrated pipeline valve to be installed also.
Described high-pressure pump is membrane pump or centrifugal pump of horizontal axis, and security personnel's filter filtering accuracy is 50-200 μ m, and the used membrane module of film condensing device is rolling NF membrane or coiled reverse osmosis membrane.
Heat exchanger also is installed on the described reflux line.
Pass through technique scheme, the utility model equipment is used for 5-hydroxytryptophan condensing crystallizing major advantage and is, directly carry out method for evaporating, concentrating and crystallizing than tradition, 5-hydroxytryptophan extract concentrates through film earlier, have energy-conservation, high-effect advantage and film is concentrated, can significantly reduce production cost.
Description of drawings
Fig. 1 is an equipment structure chart of the present utility model;
Wherein: 1. head tank, 2. feed pipe, 3. dehvery pump, 4. the ion exchange resin jar, 5. in the middle of batch can, 6. security personnel's filter, 7. high-pressure pump, 8. film condensing device, 9. dialysate tank, 10. reflux line, 11. heat exchangers, 12. valves, 13. concentrate pipelines, 14. evaporimeters, 15. crystallizing tanks.
The specific embodiment
Below in conjunction with the specific embodiment and accompanying drawing the utility model is described further.
Shown in accompanying drawing 1 equipment structure chart of the present utility model, a kind of condensing crystallizing equipment of 5-hydroxytryptophan: head tank 1 by feed pipe 2 successively with after dehvery pump 3, ion exchange resin jar 4, middle batch can 5, security personnel's filter 6, high-pressure pump 7, valve 12 link to each other, link to each other with film condensing device 8 again, the dislysate outlet of film condensing device 8 links to each other with dialysate tank 9 by pipeline, the logical reflux line 10 of film condensing device 8 concentrated solution outlets links to each other with middle batch can 5, link to each other with evaporimeter 14 by concentrating pipeline 13, evaporimeter 14 links to each other with crystallizing tank 15 again.On reflux line 10 and the concentrated pipeline 13 valve 12 is installed also, heat exchanger 11 also is installed on the reflux line.
Used high-pressure pump 6 can be membrane pump or centrifugal pump of horizontal axis, and security personnel's filter 7 is a filter bag, and filtering accuracy is 50-200 μ m, and used membrane module is rolling NF membrane or coiled reverse osmosis membrane in the membrane separation device 8.
During the equipment operation, 5-hydroxytryptophan extract pumps into ion exchange resin jar 4 by dehvery pump 3 through feed pipe 2 from head tank 1, attached through ion-exchange absorption, pump in the film condensing device by high-pressure pump 6, owing to be to adopt rolling NF membrane or coiled reverse osmosis membrane, the dislysate that does not contain the 5-hydroxytryptophan sees through film, enter in the dialysate tank, further circulation was concentrated in the batch can 5 in the middle of 5-hydroxytryptophan concentrate then was back to through reflux line 10, perhaps enter further evaporation and concentration in the evaporimeter by concentrating pipeline 13, evaporation and concentration then enters and carries out crystallisation by cooling in the crystallizing tank 15 behind certain cycles of concentration.
In sum, by being used for 5HTP condensing crystallizing major advantage, the utility model equipment is, directly carry out method for evaporating, concentrating and crystallizing than tradition, the 5HTP extract concentrates through NF membrane or reverse osmosis membrane earlier, have energy-conservation, high-effect advantage and film is concentrated, can greatly reduce production cost.

Claims (4)

1. the condensing crystallizing equipment of a 5-hydroxytryptophan, comprise the head tank, dehvery pump, ion exchange resin jar, evaporimeter, the crystallizing tank that link to each other successively by pipeline, batch can, security personnel's filter, high-pressure pump, valve, film condensing device and dialysate tank in the middle of also being equipped with successively on the pipeline after its feature also is the ion exchange resin jar, before the evaporimeter, and the film condensing device concentrated solution outlet links to each other with middle batch can by reflux line, link to each other with evaporimeter by concentrating pipeline, its feature also is on described reflux line and the concentrated pipeline valve to be installed also.
2. the condensing crystallizing equipment of a kind of 5-hydroxytryptophan as claimed in claim 1 is characterized in that described security personnel's filter filtering accuracy is 50-100 μ m.
3. the condensing crystallizing equipment of a kind of 5-hydroxytryptophan as claimed in claim 1 is characterized in that the used membrane module of described film condensing device is rolling NF membrane or coiled reverse osmosis membrane.
4. the condensing crystallizing equipment of a kind of 5-hydroxytryptophan as claimed in claim 1 is characterized in that also being equipped with on the described reflux line heat exchanger.
CN2010205282942U 2010-09-14 2010-09-14 Concentrating and crystallizing equipment for 5-hydroxyl tryptophan Expired - Fee Related CN201823337U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010205282942U CN201823337U (en) 2010-09-14 2010-09-14 Concentrating and crystallizing equipment for 5-hydroxyl tryptophan

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010205282942U CN201823337U (en) 2010-09-14 2010-09-14 Concentrating and crystallizing equipment for 5-hydroxyl tryptophan

Publications (1)

Publication Number Publication Date
CN201823337U true CN201823337U (en) 2011-05-11

Family

ID=43961898

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010205282942U Expired - Fee Related CN201823337U (en) 2010-09-14 2010-09-14 Concentrating and crystallizing equipment for 5-hydroxyl tryptophan

Country Status (1)

Country Link
CN (1) CN201823337U (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102600722A (en) * 2012-03-28 2012-07-25 于水利 Membrane separation device for high-concentration feed liquid and separation method
CN102807521A (en) * 2011-05-30 2012-12-05 江苏乐科热力科技有限公司 Concentrating crystallization process for tryptophan or glyphosate by using mechanical vapor recompression technology
CN105592901A (en) * 2013-06-24 2016-05-18 沃尔夫冈·赫恩佐 Crystallization system and process

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102807521A (en) * 2011-05-30 2012-12-05 江苏乐科热力科技有限公司 Concentrating crystallization process for tryptophan or glyphosate by using mechanical vapor recompression technology
CN102807521B (en) * 2011-05-30 2015-01-28 江苏乐科热力科技有限公司 Concentrating crystallization process for tryptophan or glyphosate by using mechanical vapor recompression technology
CN102600722A (en) * 2012-03-28 2012-07-25 于水利 Membrane separation device for high-concentration feed liquid and separation method
CN105592901A (en) * 2013-06-24 2016-05-18 沃尔夫冈·赫恩佐 Crystallization system and process
US10238988B2 (en) 2013-06-24 2019-03-26 Major Bravo Limited Crystallization system and process

Similar Documents

Publication Publication Date Title
CN201990619U (en) Lentinan extraction, separation, purification and concentration device
CN103073146A (en) Waste water treatment method and device based on forward osmosis and membrane distillation
CN103304088A (en) Recycling method of high brine waste water based on forward osmosis
CN202124582U (en) Membrane treatment system capable of extracting levodopa from velvet beans
CN101982222B (en) Device for continuously concentrating gelatin by membrane technology
CN209108958U (en) A kind of forward osmosis milk concentration systems
CN109692571A (en) A kind of milk method for concentration and system based on forward osmosis technology
CN201823337U (en) Concentrating and crystallizing equipment for 5-hydroxyl tryptophan
CN103130664A (en) Process method of extracting gamma-aminobutyric acid through membrane separation technique
CN101838294A (en) Method for preparing high-purity Tara tannic acid
CN204752740U (en) Plant micro molecule peptide powder production facility
CN101537312B (en) Multistage continuous reverse osmosis membrane concentration system and method for using the system for concentration
CN102018835A (en) Method for separating effective components in traditional Chinese medicine curculigo orchioides by membrane separation method
CN201760234U (en) Condensation device for plant extract
CN207608448U (en) Utilize the seawater desalination system of power station thermal energy production and living water
CN206315513U (en) A kind of new oily-water seperating equipment
CN201762270U (en) Production device of 5-hydroxyltryptophan
CN202909639U (en) Separation, purification and concentration device for glycyrrhizic acid extract
CN204702592U (en) The ammonia nitrogen removal device that reverse osmosis equipment and degassing equipment combine
CN208949005U (en) Primary reverse osmosis water system for preparing ergothioneine through biological fermentation synthesis
CN207405008U (en) A kind of factory high-concentration waste water demineralizer of DW system demineralized water system
CN201832564U (en) Continuous gelatin concentrating device by membrane method
CN205145993U (en) A equipment for traditional chinese medicine purification
CN202898417U (en) Bio-enzyme ultrafiltration and concentration device
CN106698786A (en) DDW (deuterium depleted water) production method and equipment

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: TIANYITANG (XIAMEN) BIOENGINEERING CO., LTD.

Free format text: FORMER NAME: ENJOYE C + G (XIAMEN) BIOENGINEERING CO., LTD.

CP01 Change in the name or title of a patent holder

Address after: Haicang District of Xiamen City, Fujian province 361000 Xinyang Street Weng Kok Road No. 289 Building No. 1 branch plant floor left

Patentee after: Xiamen Top Health Biological Engineering Co., Ltd.

Address before: Haicang District of Xiamen City, Fujian province 361000 Xinyang Street Weng Kok Road No. 289 Building No. 1 branch plant floor left

Patentee before: Yingjie Warner (Xiamen) Biological Engineering Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110511

Termination date: 20150914

EXPY Termination of patent right or utility model